» Articles » PMID: 29221211

The Prevalence of Polycystic Ovary Syndrome in Reproductive-aged Women of Different Ethnicity: a Systematic Review and Meta-analysis

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Dec 10
PMID 29221211
Citations 117
Authors
Affiliations
Soon will be listed here.
Abstract

The prevalence of PCOS was investigated in many studies in different continents. However, there is no established prevalence of PCOS for distinct ethnic groups. In the current analysis, we conducted searches in PubMed, The Cochrane Library, EMBASE, CINAHL up to Jan. 2017 to identify studies reporting prevalence of PCOS in the general female population. Forty-two studies were identified, with 13 eligible for evidence synthesis. The prevalence among different ethnicity was estimated using random effect modelling. Our results suggested the lowest prevalence in Chinese women(2003 Rotterdam criterion: 5.6% 95% interval: 4.4-7.3%), and then in an ascending order for Caucasians (1990 NIH criterion: 5.5% 95% interval: 4.8-6.3%), Middle Eastern (1990 NIH 6.1% 95% interval: 5.3-7.1%; 2003 Rotterdam 16.0% 95% interval: 13.8-18.6%; 2006 AES 12.6% 95% interval: 11.3-14.2%), and Black women (1990 NIH: 6.1% 95% interval: 5.3-7.1%).There is variation in prevalence of PCOS under different diagnostic criteria and across ethnic groups. This emphasises the need for ethnicity-specific guidelines for PCOS to prevent under- or over-diagnosis of the condition given that under-diagnosis may lead to rapid conversion of metabolic disorders for patients whereas over-diagnosis may exert negative psychological effects on patients which worsens the major symptoms of PCOS.

Citing Articles

Risk of Mental Disorders in Polycystic Ovary Syndrome: Retrospective Cohort Study of a Korean Nationwide Population-Based Cohort.

Kim Y, Chae K, Kim S, Kang S, Yoon H, Namkung J Int J Womens Health. 2025; 17:627-638.

PMID: 40061289 PMC: 11890313. DOI: 10.2147/IJWH.S490673.


The Global Burden of Polycystic Ovary Syndrome in Women of Reproductive Age: Findings from the GBD 2019 Study.

Jiang B Int J Womens Health. 2025; 17:153-165.

PMID: 39882398 PMC: 11776423. DOI: 10.2147/IJWH.S490836.


Prospective associations of adolescent obesity phenotypes with self-reported polycystic ovary syndrome diagnosis in young adulthood.

Reich L, St Fleur R, Gjelsvik A, Field A, Ziobrowski H Hum Reprod. 2025; 40(3):545-552.

PMID: 39761509 PMC: 11879201. DOI: 10.1093/humrep/deae294.


Prevalence of polycystic ovary syndrome among infertile women in the Gulf Cooperation Council (GCC) countries: A systematic review and meta-analysis.

Alam Z, Alseari S, Alameemi M, Alzaabi M, Alkhoori R, Ostlundh L Heliyon. 2025; 10(24):e40603.

PMID: 39759288 PMC: 11700273. DOI: 10.1016/j.heliyon.2024.e40603.


Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy.

Sanchez-Garrido M, Serrano-Lopez V, Ruiz-Pino F, Vazquez M, Rodriguez-Martin A, Torres E Nat Commun. 2024; 15(1):8498.

PMID: 39353946 PMC: 11445520. DOI: 10.1038/s41467-024-52898-y.


References
1.
Lauritsen M, Bentzen J, Pinborg A, Loft A, Forman J, Thuesen L . The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone. Hum Reprod. 2014; 29(4):791-801. DOI: 10.1093/humrep/det469. View

2.
Hashemipour M, Faghihimani S, Zolfaghary B, Hovsepian S, Ahmadi F, Haghighi S . Prevalence of polycystic ovary syndrome in girls aged 14-18 years in Isfahan, Iran. Horm Res. 2004; 62(6):278-82. DOI: 10.1159/000081842. View

3.
Zhao H, Lv Y, Li L, Chen Z . Genetic Studies on Polycystic Ovary Syndrome. Best Pract Res Clin Obstet Gynaecol. 2016; 37:56-65. DOI: 10.1016/j.bpobgyn.2016.04.002. View

4.
Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale H, Futterweit W . The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2008; 91(2):456-88. DOI: 10.1016/j.fertnstert.2008.06.035. View

5.
Zhao Y, Qiao J . Ethnic differences in the phenotypic expression of polycystic ovary syndrome. Steroids. 2013; 78(8):755-60. DOI: 10.1016/j.steroids.2013.04.006. View